[
  {
    "ts": "2025-12-11T12:44:22+00:00",
    "headline": "Arcellx, Inc. (ACLX) Makes Progress on Multiple Myeloma Treatment",
    "summary": "Arcellx Inc. (NASDAQ:ACLX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, the company delivered promising Pivotal Phase 2 study results of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma. The company is developing an anti-CD in partnership with Kite, a Gilead company unit, […]",
    "url": "https://finance.yahoo.com/news/arcellx-inc-aclx-makes-progress-124422702.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "340f03e8-4f3e-3abc-b325-6980f2e0b354",
      "content": {
        "id": "340f03e8-4f3e-3abc-b325-6980f2e0b354",
        "contentType": "STORY",
        "title": "Arcellx, Inc. (ACLX) Makes Progress on Multiple Myeloma Treatment",
        "description": "",
        "summary": "Arcellx Inc. (NASDAQ:ACLX) is one of the best biotech stocks to buy according to Wall Street analysts. On December 8, the company delivered promising Pivotal Phase 2 study results of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma. The company is developing an anti-CD in partnership with Kite, a Gilead company unit, […]",
        "pubDate": "2025-12-11T12:44:22Z",
        "displayTime": "2025-12-11T12:44:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/d5fe1e3cad92861737b68699e31c5a98",
          "originalWidth": 1000,
          "originalHeight": 550,
          "caption": "Arcellx, Inc. (ACLX) Makes Progress on Multiple Myeloma Treatment",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WrFS1ZAadmyYirZWy0qnDA--~B/aD01NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/d5fe1e3cad92861737b68699e31c5a98.cf.webp",
              "width": 1000,
              "height": 550,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0KCFTBRCxRJCSeJvE1prpw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d5fe1e3cad92861737b68699e31c5a98.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/arcellx-inc-aclx-makes-progress-124422702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/arcellx-inc-aclx-makes-progress-124422702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]